Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds

Shaima Wasim Khan, Noorah Al Hosani, Thaer Khaleel Swaid, Mazin M Edan, Mohammed Nabil Quraishi · 2026

Read Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds by Shaima Wasim Khan, Noorah Al Hosani, Thaer Khaleel Swaid, Mazin M Edan, Mohammed Nabil Quraishi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13311678.txt.

Description

Shaima Wasim Khan and co-authors give a 2026 cohort study on immune reactions against anti-TNF drugs in Middle Eastern patients with inflammatory bowel disease. Such reactions are a top reason these drugs stop working.

The study covered 314 treatment courses in 248 patients at a tertiary center in the United Arab Emirates. Antibodies against the drugs arose in 28.3 percent of courses over a median of two years in this cohort. Reaction-driven failure was the leading cause of stopping treatment. Drug level cutoffs that flag coming reactions were derived for both main drugs. Prior surgery was the strongest predictor of a reaction.

Catalog record

CREATORShaima Wasim Khan, Noorah Al Hosani, Thaer Khaleel Swaid, Mazin M Edan, Mohammed Nabil Quraishi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46122
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13311678

Browse the full library · About the Tower of Babel